Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age
暂无分享,去创建一个
Hitoshi Shinotoh | Tetsuya Suhara | Yasuhiko Sudo | Kiyoshi Fukushi | Toshiaki Irie | Masaomi Iyo | M. Iyo | Y. Sudo | T. Suhara | Kazutoshi Suzuki | H. Namba | K. Fukushi | T. Irie | H. Shinotoh | Kazutoshi Suzuki | S. Nagatsuka | Hiroki Namba | Shin-ichiro Nagatsuka
[1] K. Davis,et al. Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.
[2] E. Hoffman,et al. TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.
[3] K. Fukushi,et al. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. , 1994, Nuclear medicine and biology.
[4] Hitoshi Shinotoh,et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease , 1997, The Lancet.
[5] F. Shishido,et al. Evaluation of Regional Differences of Tracer Appearance Time in Cerebral Tissues Using [15O]Water and Dynamic Positron Emission Tomography , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] E K Perry,et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.
[7] E. Perry,et al. Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System , 1986, Journal of neurochemistry.
[9] K Kosaka,et al. [A biochemical study of cholinergic neurons of the post-mortem brains from the patients with Alzheimer-type dementia]. , 1984, Rinsho shinkeigaku = Clinical neurology.
[10] H. Akaike. A new look at the statistical model identification , 1974 .
[11] M. Iyo,et al. In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog , 1994, Brain Research.
[12] S Grootoonk,et al. Performance Evaluation of the Positron Scanner ECAT EXACT , 1992, Journal of computer assisted tomography.
[13] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[14] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[15] D. Kuhl,et al. In vivo studies of acetylcholinesterase activity using a labeled substrate, N‐[11C]methylpiperdin‐4‐yl propionate ([11C]PMP) , 1996, Synapse.
[16] S. Pappatà,et al. In vivo visualization of acetylcholinesterase with positron emission tomography. , 1993, Neuroreport.
[17] H. Namba,et al. Lesion of the nucleus basalis magnocellularis does not affect cerebral cortical blood flow in rats , 1991, Neuroscience Research.
[18] Y. Iwadate,et al. Quantifying brain tumor blood flow by the microsphere model with N-isopropyl-p-[123I]iodoamphetamine super-early SPECT , 1996, Annals of nuclear medicine.
[19] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[20] S. Pappatà,et al. In Vivo Imaging of Human Cerebral Acetylcholinesterase , 1996, Journal of neurochemistry.
[21] M. Iyo,et al. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.